Corrigendum re "Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer-Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial" [Eur Urol 2019;76:823-30]

Affiliations

¹ Tampere University Hospital, Tampere, Finland. Electronic address: pirkko-liisa.kellokumpu-lehtinen@tuni.fi.
² Department of Surgery, Capio S.T. Görans Hospital, Stockholm, Sweden; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
³ Department of Radiation Sciences, Oncology, Umeå University Hospital, Umeå, Sweden.
⁴ Uppsala University Hospital, Uppsala, Sweden.
⁵ Sundsvall University Hospital, Sundsvall, Sweden.
⁶ Gävle Central Hospital, Gävle, Sweden.
⁷ Seinäjoki Central Hospital, Seinäjoki, Finland.
⁸ Växjö Central Hospital, Växjö, Sweden.
⁹ 4Pharma, Turku, Finland.
¹⁰ Karlstad Central Hospital, Karlstad, Sweden.

Published Erratum

Pirkko-Liisa Kellokumpu-Lehtinen et al. Eur Urol. 2020 Dec.

. 2020 Dec;78(6):e241-e242.

doi: 10.1016/j.eururo.2020.08.035. Epub 2020 Sep 4.

¹ Tampere University Hospital, Tampere, Finland. Electronic address: pirkko-liisa.kellokumpu-lehtinen@tuni.fi.
² Department of Surgery, Capio S.T. Görans Hospital, Stockholm, Sweden; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
³ Department of Radiation Sciences, Oncology, Umeå University Hospital, Umeå, Sweden.
⁴ Uppsala University Hospital, Uppsala, Sweden.
⁵ Sundsvall University Hospital, Sundsvall, Sweden.
⁶ Gävle Central Hospital, Gävle, Sweden.
⁷ Seinäjoki Central Hospital, Seinäjoki, Finland.
⁸ Växjö Central Hospital, Växjö, Sweden.
⁹ 4Pharma, Turku, Finland.
¹⁰ Karlstad Central Hospital, Karlstad, Sweden.

No abstract available

Erratum for

Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer-Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial.
Kellokumpu-Lehtinen PL, Hjälm-Eriksson M, Thellenberg-Karlsson C, Åström L, Franzen L, Fransson AS, Leskinen MJ, Zeke M, Huttunen T, Ginman C; Investigators of the Scandinavian Prostate Cancer Study No. 13. Kellokumpu-Lehtinen PL, et al. Eur Urol. 2019 Dec;76(6):823-830. doi: 10.1016/j.eururo.2019.08.010. Epub 2019 Aug 20. Eur Urol. 2019. PMID: 31443961 Clinical Trial.